Monday, November 28, 2005


Hepatitis C - MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio


MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio
BioSpace - 1 inhibitor, in development for the treatment of chronic hepatitis C virus (HCV) infections the success of treatment for patients suffering from chronic hepatitis C infections

InterMune, Inc. (ITMN) Announces Clinical Data Presented At AASLD That Support Phase III DIRECT Trial For HCV
BioSpace - Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C who were Non-responders to Prior Therapy with

Cryoglobulinemia Is Associated With Steatosis And Fibrosis In Chronic Hcv
National AIDS Treatment Advocacy Project - No study has focused on the relationship between presence of cryoglobulin and liver steatosis which is associated with progression of liver disease. large population of patients with chronic hepatitis C, an independent association between cryoglobulin Paris, France Background and Aim: Chronic hepatitis C virus (HCV) infection is

Plymouth woman backs campaign to raise awareness of hepatitis C
Plymouth Evening Herald - is estimated that 200,000 people in England have chronic hepatitis C infection, the majority of whom are unaware of

Cambridge biotech develops hepatitis C pill
Boston Herald - Many people with chronic hepatitis C dont choose to get the current therapy because of horrible side effects that